Peritoneal Cancer
Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
- Details
ClinicalTrials.gov ID:
NCT03522246
Diagnosis Type:
NA
USOR Number:
- Address
,
P: